The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months

• Главные авторы: Yu-Xiao Wang (Автор), Hong Tao (Автор), Jian-Li Hu (Автор), Jing-Xin Li (Автор), Wei-Ming Dai (Автор), Jin-Fang Sun (Автор), Pei Liu (Автор), Jie Tang (Автор), Wen-Yu Liu (Автор), Feng-Cai Zhu (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2017-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The objective of this study was to evaluate the immunogenicity and safety of the novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup A and C-tetanus toxoid conjugate vaccine (Hib-MenAC). Methods: We conducted a non-inferiority, randomized, observer-blind, positi...